Rythm

San Francisco, United States

Rythm designs and develops consumer lab testing products including the World's Easiest Blood Test™.

$31.5M raised

Jun 2026

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Rythm raised?

Rythm has raised $31.5M in total funding. The most recent round was Series B. The last funding was announced in June 2026.

Who are Rythm's investors?

Rythm's investors include General Catalyst.

Where is Rythm headquartered?

Rythm is headquartered in San Francisco, United States.

What does Rythm do?

Rythm designs and develops consumer lab testing products including the World's Easiest Blood Test™.

What stage is Rythm at?

Rythm is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 1, 2026.

MLA

"Rythm — Funding & Investors." VCBacked, June 1, 2026, https://www.vcbacked.co/company/rythm. Accessed July 4, 2026.

APA

VCBacked. (2026). Rythm — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/rythm

Wikipedia (cite web)

{{cite web |title=Rythm — Funding & Investors |url=https://www.vcbacked.co/company/rythm |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 1, 2026.